Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Efavirenz/Emtricitabine/Tenofovir vs Atripla in Healthy Volunteers
NCT03309566Phase 4Completed
- Sponsor
- Laboratorio Elea Phoenix S.A.
- Start
- Sep 2016
- Primary completion
- Feb 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of efavirenz, emtricitabine, tenofovir disoproxil fumarate in human immunodeficiency virus infection (HIV), sponsored by Laboratorio Elea Phoenix S.A.. Started Sep 2016; status: completed.
02
Drugs
efavirenzemtricitabinetenofovir disoproxil fumarate
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT03309566.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03309566.